The EU will not extend the transparency and licensing mechanism for the export of COVID-19 vaccines.
With the Implementing Regulation (EU) 2021/2071 of November 25, 2021, the EU Commission determined that an authorization for the export of COVID-19 vaccines from the EU beyond December 31, 2021, would no longer be required.
As of January 1, 2022, exports of COVID-19 vaccines and active ingredients for their manufacture will no longer require a license from BAFA.
COVID-19 vaccines and the relevant active ingredients will be subject to export monitoring by customs for 24 months from January 1, 2022.
Detailed information can be found on the BAFA website.
Links:
Approval requirement for COVID-19 vaccines expires Dec. 31, 2021
Source: